By using AI to analyze more than 400,000 Reddit posts, researchers at Penns School of Engineering and Applied Science have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents
In studies of tirzepatide, some people lost as much as 25% of their starting weight over 88 weeks
This Program Is Built for You If You've been "doing everything right" and your body still isn't responding
If you take insulin or sulfonylureas with GLP-1 therapy, check your blood glucose when experiencing cognitive symptoms, as hypoglycemia can mimic brain fog
The former is currently awaiting FDA approval for a handful of oral, daily GLP-1 agonists, while the latter is developing combination therapies that use their muscle-preserving antibodies, trevogrumab and garetosmab, alongside GLP-1 drugs like Wegovy and Ozempic, to improve fat loss while preserving muscle mass